GlassScriptPhysician profile
Elise K Call
NPI 1174946701
$4,148.28
in general payments reported to CMS, 2019-2025
20 companies · $557 in 2025
The $557 reported for 2025 was more than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $1,198 · 2022: $986 · 2023: $733 · 2024: $674 · 2025: $557.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,964.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,964.25 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $866.04 | 2021-2025 | Otezla, Enbrel, Tavneos |
| Ucb, INC. | $675.05 | 2021-2025 | Bimzelx, Cimzia |
| Abbvie INC. | $647.05 | 2021-2025 | |
| Novartis Pharmaceuticals Corporation | $496.18 | 2021-2025 | |
| E.R. Squibb & Sons, L.L.C. | $493.42 | 2021-2025 | Orencia |
| Ani Pharmaceuticals, INC. | $245.57 | 2023-2025 | Purified Cortrophin Gel |
| Janssen Biotech, INC. | $226.25 | 2021-2025 | Tremfya |
| Aurinia Pharma U.S., INC. | $125.00 | 2023 | |
| Kyowa Kirin, INC. | $65.95 | 2023-2025 | Crysvita |
| Astrazeneca Pharmaceuticals LP | $61.44 | 2022-2025 | |
| Sobi, INC | $38.21 | 2023-2024 | |
| Lilly USA, LLC | $35.06 | 2021-2022 | |
| Pfizer INC. | $34.51 | 2024 | |
| Genentech USA, INC. | $26.64 | 2022 | |
| Glaxosmithkline, LLC. | $25.31 | 2021-2022 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alexion Pharmaceuticals, INC. | $20.70 | 2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $18.43 | 2021 | |
| Radius Health, INC. | $16.90 | 2025 | Tymlos |
| Fresenius Kabi USA, LLC | $16.11 | 2024 | Idacio |
| Sandoz INC. | $14.46 | 2023 | Hyrimoz |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Elise Call listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.